On April 29, 2021, Matt Olson hit himself in the face with a baseball in the batting cage at Tropicana Field. A freak bounce off the L-screen left him with the kind of shiner an athlete can usually only acquire by going 12 rounds with Marvin Hagler, but fortunately no lasting damage. By May 2, Olson was well enough to return to the lineup, and he hasn’t missed a game since.
Olson’s consecutive games streak now stands at 820; not only is this the longest active run in baseball, he recently passed Nellie Fox for the 11th-longest streak in MLB history. Assuming he avoids any further batting practice mishaps, Olson will end the season with the eighth-longest streak ever. Only seven players in MLB history — and 10 in all of North American top-level sports — have ever played in 1,000 straight games. Olson is due to become the 11th before the All-Star break next year. Read the rest of this entry »
Viorel Florescu/NorthJersey.com-USA TODAY NETWORK via Imagn Images
NEW YORK — “He brought that New York theater to the ballpark,” said Aaron Judge about John Sterling before Monday’s game, offering a perfect summation of the approach of the longtime Yankees broadcaster, who died earlier that day at the age of 87 in Englewood, New Jersey. Dressed in a suit and tie even though listeners couldn’t see him, prone to dropping a reference to a midcentury Broadway musical while celebrating a Yankees home run, and delivering his lines with a booming baritone capable of reaching the cheap seats, Sterling brought a unique and dramatic flair to the job.
His grandiloquent style could be polarizing, his puns agonizing. His personalized calls for each Yankee player’s home runs — from “Bernie goes boom! Bern, baby, Bern!” for Bernie Williams to “Robbie Cano, don’t ya know?” for Robinson Canó to “He sends a Tex message!” for Mark Teixeira — could sound a bit corny at times, his stentorian elongation of the word “the,” as in his oft-imitated “Thuuuuuuuuh Yankees win!” a hammy flourish.
When you root for a team, though, calls like Sterling’s punctuate the high points of fandom and the thrill of victory. Sterling never failed to convey the excitement of the ballpark with his triumphant blasts, but he easily downshifted into a calmer cadence with his partners, most notably Michael Kay and Suzyn Waldman, during more mundane moments. Such conversations are the comforting stuff of summers past, and such enduring presences in the booth offer us yardsticks by which we can measure our lives. Read the rest of this entry »
I don’t think many would quibble with me too harshly if I characterized the last two seasons for the Atlanta Braves as dreary disappointments. In 2024, the Braves were generally believed to challenge the Dodgers for the title of best team in baseball. This held true for about six weeks, but for the rest of the season, they suffered myriad injuries and played .500 ball, barely hanging onto a wild card spot before quickly being dispatched by the Padres. Going into 2025 with the hope for a healthier, bounce-back season, nothing of the sort happened. Atlanta finished at 76-86, the franchise’s first losing season since 2017. Expectations coming into this season were more muted. While the Braves were expected to be competitive (the FanGraphs projections were more optimistic than ZiPS), the excitement was certainly dampened compared to the previous two years.
So far in 2026, the Braves have defied the pundits and computers, dominating the NL East and sporting the best record in baseball, at 25-11. Their 8 1/2-game lead in the NL East isn’t an insurmountable one, but it’s quite impressive for this point in the season. No other division leader has more than a two-game lead right now! As crucially, the two teams expected to be Atlanta’s fiercest competition, the Phillies and Mets, are a bit farther behind, at 9 1/2 and 11 1/2 games back, respectively. Naturally, the success of the Braves and the struggles of Philadelphia and New York have changed how the final standings project to shake out.
ZiPS Median Projected Standings – NL East
Team
W
L
GB
Pct
Div%
WC%
Playoff%
WS Win%
80th
20th
Atlanta Braves
93
69
—
.574
68.4%
17.2%
85.6%
9.7%
100.8
85.7
Philadelphia Phillies
85
77
8
.525
20.8%
31.9%
52.7%
4.8%
92.3
78.0
New York Mets
79
83
14
.488
5.8%
17.5%
23.3%
1.3%
85.6
71.9
Miami Marlins
76
86
17
.469
4.8%
14.9%
19.6%
0.6%
84.6
70.0
Washington Nationals
67
95
26
.414
0.2%
0.9%
1.1%
0.0%
73.5
59.5
That’s quite a sea change from the start of the season. Of course, Atlanta isn’t projected to keep playing this well the rest of the way. We’re only a little over a month into the season, and we should expect some regression from the Braves as they play more games.
But just because things will normalize some does not mean that nothing has changed. I’m not convinced that Dominic Smith is a 157 wRC+ guy, or that Martín Pérez is the first person in history to figure out the secret to maintaining a sub-.200 BABIP, but there are other things about this team that I’m quite ready to believe. Matt Olson has had very big seasons before, and when healthy, Chris Sale is one of the best pitchers in baseball. Ozzie Albies isn’t going to hit .330 for the season, but he did amass the second-most WAR as a second baseman from 2018 to 2023, behind only Jose Altuve, so we have seen enough from him in the past to believe this is a true comeback campaign rather than an early-season mirage.
To get a better idea of what’s real and what’s fake, here are the ZiPS projections for the hitters currently on Atlanta’s Depth Charts roster, compared to their preseason projections.
ZiPS Projections – Braves Hitters Now vs. Preseason
Even being skeptical of a few players, there are a lot more advancers than decliners here. Of all major league hitters currently projected to get plate appearances over the rest of the season, the Braves have nine of the top 100, more than you would expect from random chance. Only three players — Austin Riley, Ronald Acuña Jr., and Mike Yastrzemski — have taken big hits, but they are still projected to be real contributors, though I’m a bit worried about Riley personally.
How does that compare to other teams? Using the rest-of-season Depth Charts playing time projections and applying both the up-to-date projections and the preseason ones to that projected playing time, we can get an idea of which teams have had something change and which teams have not.
ZiPS Projections – Team Hitters Now vs. Preseason
Name
Rest-of-Season wRC+
Preseason wRC+
Diff
Braves
112.2
108.9
3.3
Astros
107.5
105.3
2.1
Cardinals
100.9
99.3
1.6
Yankees
115.8
114.4
1.4
Cubs
111.4
110.1
1.3
Guardians
102.3
101.1
1.2
Tigers
106.0
105.0
1.0
Pirates
103.8
103.2
0.6
Marlins
100.1
99.5
0.6
White Sox
98.2
97.7
0.4
Nationals
94.9
94.6
0.3
Rays
99.3
99.2
0.1
Diamondbacks
102.6
102.5
0.1
Dodgers
120.3
120.3
0.1
Brewers
103.9
103.9
0.0
Mariners
112.2
112.9
-0.7
Angels
97.9
98.5
-0.7
Rockies
91.5
92.3
-0.7
Royals
101.9
102.7
-0.8
Blue Jays
106.2
107.1
-0.9
Orioles
112.9
113.9
-0.9
Twins
104.6
105.9
-1.3
Athletics
108.6
110.1
-1.5
Reds
99.8
101.5
-1.8
Rangers
105.4
107.3
-1.9
Phillies
106.8
108.7
-1.9
Padres
107.5
109.7
-2.2
Red Sox
101.2
103.5
-2.3
Giants
104.3
107.3
-3.0
Mets
110.3
114.4
-4.0
Atlanta’s offensive projection has improved more than that of any other team, so it isn’t just smoke and mirrors producing these results. At the risk of veering off topic, the 14-22 Astros’ having the second-most improved offensive projection is quite an awkward data point for the team’s struggling pitching staff. Conversely, even if you’re generally confident that the Phillies and Mets (and Red Sox) will right the ship, the projections are less optimistic than they were in March.
Let’s repeat the exercise with the pitchers:
ZiPS Projections – Braves Pitchers Now vs. Preseason
ZiPS is confident that Atlanta’s offensive improvements are legitimate, but it’s considerably less so when it comes to the pitching staff. I’ve already made a crack about Pérez, but ZiPS is also skeptical about Bryce Elder’s strides. Overall, it still sees the rotation as risky, though it is more bullish on several of the team’s relievers.
(For those curious, the most improved hitter and pitcher in baseball, from a projection standpoint, is Chase DeLauter and Mason Miller, respectively.)
ZiPS Projections – Team Pitchers Now vs. Preseason
Team
Rest-of-Season ERA+
Preseason ERA+
Diff
Padres
102.9
100.3
2.5
Yankees
104.3
101.9
2.4
Phillies
115.5
113.3
2.2
Brewers
105.5
103.3
2.2
Dodgers
111.4
109.6
1.8
Blue Jays
109.2
107.4
1.8
Mets
105.0
103.3
1.7
Marlins
101.3
99.8
1.5
Angels
95.2
94.0
1.3
White Sox
91.6
90.4
1.2
Pirates
111.5
110.5
1.1
Rockies
96.5
95.5
1.0
Tigers
107.8
107.0
0.8
Cubs
100.2
99.6
0.5
Mariners
104.7
104.5
0.1
Rangers
95.5
95.4
0.0
Twins
102.7
102.8
-0.2
Braves
106.9
107.2
-0.4
Giants
105.2
105.6
-0.4
Guardians
109.4
109.9
-0.5
Reds
96.3
96.8
-0.5
Diamondbacks
106.8
107.4
-0.6
Orioles
101.6
102.3
-0.7
Astros
104.3
105.3
-1.0
Athletics
94.2
95.2
-1.0
Rays
105.1
106.3
-1.2
Cardinals
97.7
99.0
-1.4
Nationals
89.8
91.1
-1.4
Royals
101.0
102.6
-1.6
Red Sox
108.5
110.6
-2.1
It’s kind of funny to see the Phillies so high up on this list, but they have allowed a .349 BABIP over 35 games, a freakishly high number that can’t possibly be sustained. One can see why the Yankees and Padres have been so strong in the early going, though their success is a story for another day.
Is the NL East race actually over? The projections and Betteridge’s law of headlines say no. But it is true that the Braves have flipped the script. It’s not as over for the Mets or Phillies as the vibes indicate, but if they are going to mount a comeback, they better start fairly soon. If not, they’ll quickly run out of calendar.
The best team in baseball will be without its biggest star for a few weeks.
The Braves placed Ronald Acuña Jr. on the injured list Sunday with a strained left hamstring. Acuña exited Saturday’s game after pulling up in considerable pain while running out a groundout. Manager Walt Weisstold reporters that imaging revealed a Grade 1 strain, the least severe grade. According to MLB.com, Weiss said:
“It’s not going to be just a couple days. It’s gonna be more than that, so we need to put him on the IL, and hopefully it’ll be sooner than later. No idea with these soft tissue injuries how long they’re gonna take, but I think the silver lining is that the MRI showed it wasn’t too serious.”
While many players return from Grade 1 hamstring strains in just a couple weeks, or even following the 10-day minimum, this is an injury that can linger and delay a return.
This is, obviously, less than ideal for the Braves. Acuña is their best player and was projected in the preseason as the ninth-best position player in baseball with 5.4 WAR, according to our Depth Charts. Though his performance hasn’t been spectacular thus far, with a 111 wRC+ in 152 plate appearances, his .381 xwOBA and 12.2% barrel rate — along with strong strikeout and walk rates — suggest he hasn’t missed a beat this year, coming off his bounce-back 2025 season.
Of course, last year was a comeback campaign because Acuña missed most 2024 (and the early part of 2025) after tearing his ACL. He also missed chunks of 2021 and 2022 with a torn ACL in his other knee. In 2018, he missed about a month with a mild ACL sprain. That means Acuña’s hamstring strain is his fourth lower body injury requiring IL time in his career. Read the rest of this entry »
The moment may prove fleeting, but at this writing, the Braves have a claim as the best team in baseball. At the outset of this season, Atlanta looked as though it might be headed for disaster yet again due to injuries and absences, with another Jurickson Profarsuspension and the loss of Spencer Strider providing a particular sense of déjà vu. Instead of stumbling out of the gate, however, and even with a far-from-complete roster, the 2026 Braves have dominated opponents on both sides of the ball. At 21-9, they own the majors’ best record — and it appears they’ll get Strider back soon, as well.
Nearly five weeks in, the Braves haven’t lost a series. They kicked things off at Truist Park by taking two out of three from both the Royals and A’s, then went on the road and split a four-game set with the Diamondbacks before taking two out of three from the Angels. Upon returning to Atlanta, they took two of three from both the Guardians and Marlins, and after that sandwiched a pair of series wins against the reeling Phillies — a three-game sweep in Philadelphia and then two out of three at home — around a three-out-of-four series win in Washington. That’s eight series wins and one tie to date; by comparison, the Dodgers and Yankees (both 20-10) have each dropped pair of three-game series and split a four-gamer.
To be fair, after last year’s 76-86 dud and the retirement of manager Brian Snitker (replaced by bench coach Walt Weiss), the Braves were still essentially projected as NL East co-favorites alongside the Mets, according to our Playoff Odds, with a forecast for 89.6 wins, a 30.6% chance of winning the division, and a 79.0% chance of making the playoffs. Still, few expected them to return to dominate in such fashion. Through 30 games, they’ve matched the second-best start in franchise history, a record shared by the division-winning 1969 and 2000 editions. The only time they’ve started better was in 1997, when they went 22-8 and finished 101-61. They’ve gone 16-6 against sub-.500 teams without even getting a shot at the struggling Mets, and 5-3 against teams .500 or better. Their current record isn’t a fluke, in that they’ve actually got slightly higher Pythagorean- and Base Runs-projected winning percentages (.722 and .695, respectively) than their actual mark; both of those rank second in the majors behind the Dodgers, while their +68 run differential is tops. The Braves have run up those numbers by scoring a major league-high 5.70 runs per game and allowing just 3.43 per game, tied with the Yankees for second in the majors and behind only the Dodgers. Read the rest of this entry »
One of the foundational assumptions of the past 10 years in baseball is that the Braves will always figure something out. Their run of six straight division titles from 2018 to 2023 placed them in a conversation with the Dodgers and Astros as the one of the most consistently successful teams in baseball.
The Braves run a big payroll, but not on a level that allows them to outspend their mistakes. And those mistakes have been few. They always make smart trades, always get their star players to sign under-market extensions, always develop their own talent well. You could argue that the Braves have had more success developing undersized right-handed college starters named Spencer than the Orioles have had with their own pitching prospects of any size, name, and origin over the past 30 years.
But as Atlanta tries to bounce back from its first losing season since 2017, that sense of inevitability is fading. Spencer Schwellenbach is out until midseason with bone spurs in his elbow, and as of Monday, Spencer Strider has a strained oblique muscle and will start the season on the IL. Read the rest of this entry »
Ben Lindbergh and Meg Rowley banter about speedster Braiden Ward’s record spring, whether there’s a baseball equivalent of Bam Adebayo’s 83-point game, and Paradise being a baseball show, then preview the 2026 Atlanta Braves (38:00) with From the Diamond’s Grant McAuley, and the 2026 Chicago White Sox (1:29:45) with Sox Machine’s James Fegan.
Below is an analysis of the prospects in the farm system of the Atlanta Braves. Scouting reports were compiled with information provided by industry sources as well as my own observations. This is the sixth year we’re delineating between two anticipated relief roles, the abbreviations for which you’ll see in the “position” column below: MIRP for multi-inning relief pitchers, and SIRP for single-inning relief pitchers. The ETAs listed generally correspond to the year a player has to be added to the 40-man roster to avoid being made eligible for the Rule 5 draft. Manual adjustments are made where they seem appropriate, but we use that as a rule of thumb.
A quick overview of what FV (Future Value) means can be found here. A much deeper overview can be found here.
All of the ranked prospects below also appear on The Board, a resource the site offers featuring sortable scouting information for every organization. It has more details (and updated TrackMan data from various sources) than this article and integrates every team’s list so readers can compare prospects across farm systems. It can be found here. Read the rest of this entry »
In 2024, 11 years after he was the consensus no. 1 prospect in the game, Jurickson Profar finally broke out, setting career highs in home runs (24), wRC+ (139) and WAR (4.3), making his first All-Star team, and helping the Padres to an NL Wild Card berth. He cashed in that winter; after never making more than $7.75 million in a season, Profar signed a three-year, $42 million deal with the Braves. Four games into his tenure with his new team, however, he drew an 80-game suspension for violating the Joint Drug Agreement. While he was productive upon returning and figured prominently in the plans of a team expected to contend for the NL East title this season, on Tuesday, the 33-year-old outfielder drew a second PED suspension, this one for the entire 2026 season.
Profar wasn’t the only player reported to be facing a PED suspension on Tuesday, or even the only NL East outfielder who had run afoul of the game’s drug policy. According to multiplesources, the Phillies’ Johan Rojas has an 80-game suspension looming for a first-time offense. While MLB officially announced Profar’s suspension in a press release sent at 6:47 p.m. ET on Tuesday — over six hours after ESPN’s Jeff Passan first broke the news — Rojas’ is not yet official.
Both players are reportedly appealing their suspensions. An hour after Passan’s tweet, The Athletic’s Ken Rosenthal reported that the Major League Baseball Players Association is filing a grievance on Profar’s behalf. It’s not clear yet on what grounds the union is challenging the suspension, but such a case would be heard by MLB’s independent arbitrator, Martin F. Scheinman. Later that afternoon, The Athletic’s Charlotte Varnes and Matt Gelb reported that Rojas is appealing his suspension, as well. He is starting in center field and batting seventh in Philadelphia’s exhibition game on Wednesday against Team Canada. Read the rest of this entry »
Well, Chris Sale no longer has to do what he does under the cloud of a one-year contract. On Tuesday, the Braves announced they’d signed their soon-to-be 37-year-old ace to a one-year contract extension with a team option for 2028. The deal represents a huge raise. Sale is making $18 million this year – the team option year at the end of the two-year extension he signed back in 2024 – and the new extension will pay him $27 million in 2027. If the Braves pick up the 2028 option, they’ll pay him $30 million. No word of a buyout for that final year has been reported, and the announcement included no mention of a 1% donation to the Atlanta Braves Foundation.
Even though the Braves are not getting the kind of discount you associate with a contract extension, this seems like a no-brainer for them. Yes, they’re paying ace prices for the age-37 (and possibly age-38) season of a pitcher whose injury history includes a Tommy John surgery and five variations on the word “fracture.” But Sale really is an ace, and his performance has showed no signs of dropping off. Since he arrived in Atlanta in 2024 (and for the sake of Red Sox fans, I won’t mention how he got there), Sale has a 25-8 record with a 2.46 ERA and 2.33 FIP. He’s struck out nearly a third of the batters he’s faced, and he won the Cy Young award in his first season with the team. In 2025, his four-seamer averaged 94.8 mph. That’s above average, especially for a left-handed starter, and especially for someone with a funky sidearm delivery, and especially when you factor in the bump in effective velocity due to the above-average extension from his 6-foot-6 frame. That’s a lot of especiallys making Sale’s velocity play up, and it’s reassuring to know that it has looked pretty stable in recent years.